Protega Pharmaceuticals Inc. is the culmination of the efforts of a group of diverse professionals with winning experience in pharmaceutical corporate development ranging from specialty start-ups to managing critical areas in large, well-established pharmaceutical corporations. At the lead as Chairman and Chief Executive Officer is Stefan Aigner, MD, CFA. Dr. Aigner brings over 30 years of healthcare industry experience. Dr. Aigner orchestrated the development of SentryBond Technology, an abuse deterrent that forms the basis for the Protega product line. More about Dr. Aigner’s background can be found on our Management Team page.
As an integral part of the Protega team, Hafid Touam contributes his expertise in the role of Chief Business Officer. Mr. Touam is also a pharmaceutical veteran with more than 30 years of industry experience in drug delivery systems and product development technology. Mr. Touam’s profile, as well as the profiles of other key members of the Protega Team, can be found on the Management Team page.
Protega Pharma is a privately held specialty pharmaceutical company dedicated to the advancement of prescription drug abuse deterrence through continued innovation and development. Recognizing the unmet public health need to combat the escalating crisis of prescription opioid abuse and misuse, Protega has responded with a line of immediate-release abuse-deterrent opioid products. We’re optimistic that this unique approach will initiate further development within the area of abuse management.
Our Social Responsibility
We apply our expertise in science and innovation to society’s health challenges. Corporate responsibility is the core of our business strategy. Our product line is fueled by human and scientific insights that drive change. Protega Pharma strives to solve the business and human challenges to positively impact health experiences.
Protega is committed to act on behalf of patients and customers, employees, communities, environment, and other stakeholders. As a responsible corporate citizen, we seek to actively improve the health of the communities in which we live, work, and serve. We believe our inclusive culture supports improved outcomes for all patients and we seek diversity in all aspects of our business.
We are committed to scientific excellence in pharmaceutical research and development, thereby providing innovative and high-quality products that address the unmet medical needs of patients and healthcare professionals.